BriaCell Therapeutics News

BriaCell Therapeutics | 8-K: Current report

Apr 2 16:11 ET

BriaCell Therapeutics | 8-K: Current report

Jan 31 17:28 ET

BriaCell Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Jan 22 00:00 ET

BriaCell Therapeutics | DEF 14A: Definitive information statements

Jan 9 00:00 ET

BriaCell Therapeutics | 8-K: Current report

Dec 20, 2023 16:05 ET

BriaCell Therapeutics | 8-K: Current report

Dec 14, 2023 17:00 ET

BriaCell Therapeutics | 8-K: Current report

Nov 30, 2023 07:00 ET

BriaCell Therapeutics | 8-K: Current report

Nov 3, 2023 08:45 ET

BriaCell Therapeutics | 8-K: Current report

Oct 25, 2023 17:25 ET

BriaCell Therapeutics | 8-K: Current report

Sep 8, 2023 08:49 ET

BriaCell Therapeutics | 8-K: Current report

Sep 7, 2023 16:30 ET

BriaCell Therapeutics | 8-K: Current report

Aug 31, 2023 17:43 ET

BriaCell Therapeutics | 8-K: Current report

Aug 31, 2023 17:25 ET

BriaCell Therapeutics | 8-K: Current report

Aug 25, 2023 16:52 ET

BriaCell Therapeutics | 8-K: Current report

Aug 21, 2023 16:05 ET

BriaCell Therapeutics | DEF 14A: Definitive information statements

Jul 26, 2023 16:05 ET

BriaCell Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Jun 30, 2023 16:30 ET

BriaCell Therapeutics | 8-K: Current report

Jun 27, 2023 09:30 ET

BriaCell Therapeutics | 8-K: Current report

May 31, 2023 16:30 ET

BriaCell Therapeutics | 8-K: Current report

May 22, 2023 11:48 ET